Evidence map›Paper›PMID 37115319›Full record

ArticleHistochemistry and cell biology2023

MicroRNA-598 inhibition ameliorates LPS-induced acute lung injury in mice through upregulating Ebf1 expression.

Qi Zhao, Lei He, Junwu Zhang, Hong Li, Wanying Li, Zhihui Zhou, Yuanyuan Li

Open access · bronzeAbstract read
In one paragraph

Article in Histochemistry and cell biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Extracellular vesicle-mediated mechanisms and therapeutic potential in acute lung injury.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Qi ZhaoXianYang Vocational Technical College, Tongyi Avenue, Fengxi New Town, Xixian, Xi'an, 712000, Shaanxi, China.
Lei HePharmaceutical Factory of Shaanxi, University of Chinese Medicine, No. 1 Weiyang Middle Road, Qindu, Distrtict, Xianyang, Shaanxi, China.
Junwu ZhangShaanxi University of Chinese Medicine, Xixian Avenue, Xi'an, 712046, Shaanxi, China. zjw20221008@163.com.
Hong LiShaanxi University of Chinese Medicine, Xixian Avenue, Xi'an, 712046, Shaanxi, China. sxefyy.lh@163.com.
Wanying LiPharmaceutical Factory of Shaanxi, University of Chinese Medicine, No. 1 Weiyang Middle Road, Qindu, Distrtict, Xianyang, Shaanxi, China.
Zhihui ZhouSecond Affiliated Hospital of Shaanxi University of Chinese Medicine, No. 831, Longtaiguan Road, Fengxi New Town, Xixian, Xi'an, 712000, Shaanxi, China.
Yuanyuan LiSecond Affiliated Hospital of Shaanxi University of Chinese Medicine, No. 831, Longtaiguan Road, Fengxi New Town, Xixian, Xi'an, 712000, Shaanxi, China.
Shaanxi University of Chinese Medicine · CNAffiliated Hospital of Shaanxi University of Chinese Medicine · CNJiaxing Vocational Technical College · CN

Funding

key research and development plan "COVID-19 Emergency Prevention and Control" science and technology special project of Xianyang City in 2020 2020k02-85Subject Innovation Team of Shaanxi University of Chinese Medicine 2019-YS03the key research and development project of Xianyang City in 2019 2019k02-38
6 · The paper itself

Abstract

Acute lung injury is a critical acute respiratory distress syndrome (ARDS) with high morbidity and mortality. MicroRNAs (miRNAs) have been demonstrated to play important roles regulating acute lung injury development. In this study, we found that the expression of miR-598 was significantly upregulated in the lung tissues of mice with lipopolysaccharide (LPS)-induced acute lung injury. Both loss-of-function and gain-of-function studies were performed to evaluate the function of miR-598 in acute lung injury. The results showed that inhibition of miR-598 attenuated inflammatory response, oxidative stress, and lung injury in mice treated with LPS, while overexpression of miR-598 exacerbated the LPS-induced acute lung injury. Mechanistically, transcription factor Early B-cell Factor-1 (Ebf1) was predicted and validated as a downstream target of miR-598. Overexpression of Ebf1 attenuated LPS-induced production of inflammatory cytokine TNF-α and IL-6, ameliorated LPS-induced oxidative stress, promoted proliferation, and inhibited apoptosis in murine lung epithelial-15 (MLE-15) cells. Moreover, we demonstrated that Ebf1 knockdown abolished the protective effect of miR-598 inhibition in LPS-treated MLE-15 cells. In summary, miR-598 inhibition ameliorates LPS-induced acute lung injury in mice through upregulating Ebf1 expression, which might provide potential therapeutic treatment for acute lung injury.

Indexed as

Acute Lung InjuryMicroRNAsAnimalsApoptosisCytokinesLipopolysaccharidesMiceNF-kappa BTrans-ActivatorsCytokinesEbf1 protein, mouseLipopolysaccharidesMicroRNAsMIRN598 microRNA, mouseNF-kappa BTrans-ActivatorsAcute lung injuryEbf1InflammationmiR-598Oxidative stress

Identifiers

PMID37115319
PMCPMC10141928
OpenAlexW4367312910

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.